Relapsed/Refractory FLT3-Mutated AML | OncLive
Relapsed/Refractory FLT3-Mutated AML | OncLive
Jan 28, 2020
onclive.com
FLT3-ITD Mutated AML: Quizartinib, Venetoclax, & Decitabine Triple Combination
FLT3-ITD Mutated AML: Quizartinib, Venetoclax, & Decitabine Triple C…
143 viewsDec 15, 2023
vumedi.com
Treatment Approaches for TP53-Mutated AML | OncLive
Treatment Approaches for TP53-Mutated AML | OncLive
Sep 9, 2021
onclive.com
FLT3-Mutated AML: Early Aggressive Therapy vs Transplant
FLT3-Mutated AML: Early Aggressive Therapy vs Transplant
Jul 20, 2020
onclive.com
Challenges in the Management of TP53-Mutated AML: Potential Strategies to Improve Outcomes
Challenges in the Management of TP53-Mutated AML: Potential Strat…
481 viewsMar 5, 2024
vumedi.com
Frontline Treatment in Patients With IDH-Mutated AML Unfit for Intensive Chemotherapy | OncLive
Frontline Treatment in Patients With IDH-Mutated AML Unfit for Intensi…
Feb 28, 2023
onclive.com
Acute myeloid leukemia, or #AML for short, is an aggressive type of blood cancer in which the bone marrow makes unhealthy blood cells. There are different subtypes of AML that are each caused by a unique mutation (or change) in the body’s genes. | Astellas Pharma US
0:11
Acute myeloid leukemia, or #AML for short, is an aggressive type of …
113.8K viewsFeb 24, 2021
FacebookAstellas Pharma US
Activity, Tolerability and Resistance Profile of the Menin Inhibitor Zifto…
Jul 12, 2023
onclive.com
Understanding Anti-Money Laundering (AML): Key Processe…
6 months ago
investopedia.com
Unmet Needs for Patients With AML | Targeted Oncology - Immunother…
Jan 3, 2024
targetedonc.com
13:50
Phase 1b Study of Azacitidine, Venetoclax and Revumenib in Ne…
1 week ago
onclive.com
Dr Fedorov on the Use of Quizartinib vs Midostaurin in FLT3 AML | Onc…
Apr 26, 2024
onclive.com
Treatment Options for AML Patients with IDH2, RUNX1, or DNMT3A Mu…
Aug 8, 2022
targetedonc.com
5:56
Treating AML
75.1K viewsNov 27, 2019
YouTubeYou and AML
6:35
Understanding AML
174.9K viewsDec 2, 2019
YouTubeYou and AML
Azacitidine, venetoclax & gilteritinib in older/unfit patients with FLT3-m…
728 viewsJun 20, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
Which AML patients benefit most from venetoclax treatment?
3.6K viewsFeb 17, 2022
YouTubeAML Hub
Dr. Röllig on FLT3 ITD/NPM1 Mutation Status for Patients With …
1.4K viewsSep 21, 2015
YouTubeTargeted Oncology
MRD negativity in NPM1-mutated AML: the influence of co-occurrin…
171 viewsDec 13, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
Secondary-type mutations do not impact the favorable prognosis in …
319 viewsFeb 21, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
7:02
Acute Myeloid Leukemia (AML)
21K viewsAug 25, 2013
YouTubeNEJM Group
1:27
What Is AML?
23.1K viewsApr 19, 2018
YouTubeBlood Cancer United
4:28
Understanding Myelodysplastic Syndromes (MDS)
72.5K viewsJul 27, 2018
YouTubeYou and MDS
7:45
Diagnosing AML, AML-MRC, and tAML
8.8K viewsNov 27, 2019
YouTubeYou and AML
2:05
Expanded treatment options for Acute Myeloid Leukemia (AML)
22.4K viewsDec 10, 2018
YouTubeDana-Farber Cancer Institute
9:42
Acute leukemia | Hematologic System Diseases | NCLEX-RN | Kh…
364.8K viewsMay 7, 2014
YouTubekhanacademymedicine
3:42
Midostaurin in c-KIT or FLT3-ITD mutated t(8;21) AML
893 viewsJun 30, 2020
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:07
Overcoming Acute Myelogenous Leukemia - Max's Story
16.8K viewsDec 21, 2012
YouTubeMayo Clinic
27:18
Acute Myelogenous Leukemia (AML) & Chronic Myelogenous Leukemi…
25.6K viewsDec 6, 2015
YouTubethe study spot
2:38
Acute Myeloid Leukemia (AML) - Treatment - Hematology and Onco…
92.2K viewsAug 18, 2018
YouTubeMedicosis Perfectionalis
See more videos
Static thumbnail place holder